STOCK TITAN

Westlake Chemical Partners LP Announces Second Quarter 2023 Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
  • Declared quarterly distribution of $0.4714 per unit; 36th consecutive quarterly distribution

HOUSTON--(BUSINESS WIRE)-- Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2023 of $11.9 million, or $0.34 per limited partner unit, a decrease of $4.5 million compared to second quarter 2022 net income of $16.4 million. The reduction in Partnership net income in the second quarter of 2023 compared to the second quarter of 2022 was the result of lower production volumes, due to the planned Calvert City maintenance turnaround, and higher interest expense. Cash flows from operating activities in the second quarter of 2023 were $98.5 million, a decrease of $22.4 million compared to second quarter 2022 cash flows from operating activities of $120.9 million. The decrease was primarily due to lower net income at OpCo. For the three months ended June 30, 2023, MLP distributable cash flow was $15.0 million, a decrease of $4.6 million compared to second quarter 2022 MLP distributable cash flow. The decrease in MLP distributable cash flow was primarily attributable to impacts from the Calvert City turnaround and higher interest expense.

Second quarter 2023 net income attributable to the Partnership of $11.9 million decreased by $3.0 million compared to first quarter 2023 net income of $14.9 million due to impacts from the Calvert City turnaround. Second quarter 2023 cash flows from operating activities of $98.5 million decreased by $46.4 million compared to first quarter 2023 cash flows from operating activities of $144.9 million due to lower net income at OpCo and cash costs associated with the Calvert City turnaround. Second quarter 2023 MLP distributable cash flow of $15.0 million decreased by $2.6 million compared to first quarter 2023 MLP distributable cash flow of $17.6 million, primarily due to lower net income at OpCo.

"As expected, the Partnership's net income and distributable cash flow in the second quarter of 2023 were below both the prior year and prior quarter levels due to the planned maintenance turnaround at Calvert City, which only occurs roughly every seven years. While costs to perform the maintenance were fully paid for by reserves from our ethylene sales agreement with Westlake, the reduced production volume at Calvert City for the duration of the turnaround negatively impacted our sales volume, net income and distributable cash flow," said Albert Chao, President and Chief Executive Officer. "Due to the strong efforts of OpCo's employees, the Calvert City turnaround was completed on schedule during the second quarter. Looking forward, we expect distributable cash flow to improve in the second half of 2023 from second quarter levels now that our maintenance work is behind us. We remain excited about the strong underlying fundamentals of the Partnership and the stability provided to our financial results by our ethylene sales agreement that provides a fixed margin on 95% of our production."

On August 1, 2023, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the second quarter of 2023 of $0.4714 per unit to be payable on August 25, 2023 to unitholders of record as of August 11, 2023, representing the 36th consecutive quarterly distribution to our unitholders. MLP distributable cash flow provided trailing twelve-month coverage of 1.05x the declared distributions for the second quarter of 2023.

OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures.

The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to the ability to deliver value, returns, predictable cash flows and distributions to unitholders, demand for ethylene and expected margins and production volumes, contracted volumes, the expectation that strong distributions will continue, and the nature of the sales agreement with Westlake, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, the COVID-19 pandemic and the response thereto; operating difficulties; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions, including inflation, interest rates and possible recession; actions and commitments of Westlake Corporation; actions of third parties; inclement or hazardous weather conditions, including flooding, and the physical impacts of climate change; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; difficulty collecting receivables; inability of our customers to take delivery; fires, explosions or other industrial accidents; our ability to borrow funds and access capital markets; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC in March 2023, and Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, which was filed with the SEC in May 2023.

This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.

Use of Non-GAAP Financial Measures

This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of income, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake Corporation's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.

Westlake Chemical Partners LP

Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.

Westlake Chemical Partners LP Conference Call Information:

A conference call to discuss Westlake Chemical Partners' second quarter 2023 results will be held Thursday, August 3, 2023 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, it is necessary to pre-register at https://register.vevent.com/register/BIb635b9f0d11a495fb699666f55842f0b. Once registered, you will receive a phone number and unique PIN number.

A replay of the conference call will be available beginning two hours after its conclusion. The conference call and replay will be available via webcast at https://edge.media-server.com/mmc/p/8hay9rav.

WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS")

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2023

 

2022

 

2023

 

2022

 

 

 

 

 

 

 

 

 

 

 

(In thousands of dollars, except per unit data)

Revenue

 

 

 

 

 

 

 

 

Net sales—Westlake Corporation ("Westlake")

 

$

224,575

 

 

$

365,112

 

 

$

482,046

 

 

$

655,769

 

Net co-products, ethylene and other sales—third parties

 

 

39,602

 

 

 

83,673

 

 

 

89,808

 

 

 

155,416

 

Total net sales

 

 

264,177

 

 

 

448,785

 

 

 

571,854

 

 

 

811,185

 

Cost of sales

 

 

176,455

 

 

 

351,483

 

 

 

378,059

 

 

 

622,444

 

Gross profit

 

 

87,722

 

 

 

97,302

 

 

 

193,795

 

 

 

188,741

 

Selling, general and administrative expenses

 

 

7,229

 

 

 

9,919

 

 

 

15,143

 

 

 

18,146

 

Income from operations

 

 

80,493

 

 

 

87,383

 

 

 

178,652

 

 

 

170,595

 

Other income (expense)

 

 

 

 

 

 

 

 

Interest expense—Westlake

 

 

(6,117

)

 

 

(2,859

)

 

 

(13,432

)

 

 

(5,058

)

Other income, net

 

 

1,061

 

 

 

90

 

 

 

1,881

 

 

 

65

 

Income before income taxes

 

 

75,437

 

 

 

84,614

 

 

 

167,101

 

 

 

165,602

 

Provision for income taxes

 

 

173

 

 

 

175

 

 

 

385

 

 

 

338

 

Net income

 

 

75,264

 

 

 

84,439

 

 

 

166,716

 

 

 

165,264

 

Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP ("OpCo")

 

 

63,378

 

 

 

68,001

 

 

 

139,938

 

 

 

132,632

 

Net income attributable to Westlake Partners

 

$

11,886

 

 

$

16,438

 

 

$

26,778

 

 

$

32,632

 

 

 

 

 

 

 

 

 

 

Net income per limited partner unit attributable to Westlake Partners (basic and diluted)

 

 

 

 

 

 

 

 

Common units

 

$

0.34

 

 

$

0.47

 

 

$

0.76

 

 

$

0.93

 

 

 

 

 

 

 

 

 

 

Distributions declared per unit

 

$

0.4714

 

 

$

0.4714

 

 

$

0.9428

 

 

$

0.9428

 

 

 

 

 

 

 

 

 

 

MLP distributable cash flow

 

$

14,985

 

 

$

19,584

 

 

$

32,536

 

 

$

38,875

 

 

 

 

 

 

 

 

 

 

Distributions declared

 

 

 

 

 

 

 

 

Limited partner units—publicly and privately held

 

$

9,946

 

 

$

9,938

 

 

$

19,892

 

 

$

19,881

 

Limited partner units—Westlake

 

 

6,658

 

 

 

6,657

 

 

 

13,315

 

 

 

13,314

 

Total distributions declared

 

$

16,604

 

 

$

16,595

 

 

$

33,207

 

 

$

33,195

 

EBITDA

 

$

108,594

 

 

$

118,482

 

 

$

234,209

 

 

$

232,951

 

WESTLAKE CHEMICAL PARTNERS LP

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

 

 

June 30,
2023

 

December 31,
2022

 

 

 

 

 

 

 

(In thousands of dollars)

ASSETS

 

 

 

 

Current assets

 

 

 

 

Cash and cash equivalents

 

$

59,434

 

 

$

64,782

 

Receivable under the Investment Management Agreement—Westlake

 

 

94,230

 

 

 

64,996

 

Accounts receivable, net—Westlake

 

 

45,467

 

 

 

90,965

 

Accounts receivable, net—third parties

 

 

17,443

 

 

 

20,030

 

Inventories

 

 

3,260

 

 

 

4,715

 

Prepaid expenses and other current assets

 

 

718

 

 

 

305

 

Total current assets

 

 

220,552

 

 

 

245,793

 

Property, plant and equipment, net

 

 

963,490

 

 

 

990,213

 

Other assets, net

 

 

151,545

 

 

 

135,973

 

Total assets

 

$

1,335,587

 

 

$

1,371,979

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

Current liabilities (accounts payable and accrued and other liabilities)

 

$

66,317

 

 

$

66,941

 

Long-term debt payable to Westlake

 

 

399,674

 

 

 

399,674

 

Other liabilities

 

 

1,638

 

 

 

1,656

 

Total liabilities

 

 

467,629

 

 

 

468,271

 

Common unitholders—publicly and privately held

 

 

476,791

 

 

 

480,643

 

Common unitholder—Westlake

 

 

51,282

 

 

 

53,859

 

General partner—Westlake

 

 

(242,572

)

 

 

(242,572

)

Total Westlake Partners partners' capital

 

 

285,501

 

 

 

291,930

 

Noncontrolling interest in OpCo

 

 

582,457

 

 

 

611,778

 

Total equity

 

 

867,958

 

 

 

903,708

 

Total liabilities and equity

 

$

1,335,587

 

 

$

1,371,979

 

WESTLAKE CHEMICAL PARTNERS LP

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Six Months Ended June 30,

 

 

2023

 

2022

 

 

 

 

 

 

 

(In thousands of dollars)

Cash flows from operating activities

 

 

 

 

Net income

 

$

166,716

 

 

$

165,264

 

Adjustments to reconcile net income to net cash provided by operating activities

 

 

 

 

Depreciation and amortization

 

 

53,676

 

 

 

62,291

 

Net loss on disposition and other

 

 

725

 

 

 

6,801

 

Other balance sheet changes

 

 

22,286

 

 

 

(8,689

)

Net cash provided by operating activities

 

 

243,403

 

 

 

225,667

 

Cash flows from investing activities

 

 

 

 

Additions to property, plant and equipment

 

 

(17,169

)

 

 

(32,334

)

Investments with Westlake under the Investment Management Agreement

 

 

(164,116

)

 

 

(170,000

)

Maturities of investments with Westlake under the Investment Management Agreement

 

 

135,000

 

 

 

147,000

 

Net cash used for investing activities

 

 

(46,285

)

 

 

(55,334

)

Cash flows from financing activities

 

 

 

 

Proceeds from debt payable to Westlake

 

 

98,500

 

 

 

 

Repayment of debt payable to Westlake

 

 

(98,500

)

 

 

 

Quarterly distributions to noncontrolling interest retained in OpCo by Westlake

 

 

(169,259

)

 

 

(135,818

)

Quarterly distributions to unitholders

 

 

(33,207

)

 

 

(33,203

)

Net cash used for financing activities

 

 

(202,466

)

 

 

(169,021

)

Net increase (decrease) in cash and cash equivalents

 

 

(5,348

)

 

 

1,312

 

Cash and cash equivalents at beginning of period

 

 

64,782

 

 

 

17,057

 

Cash and cash equivalents at end of period

 

$

59,434

 

 

$

18,369

 

WESTLAKE CHEMICAL PARTNERS LP

 

RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME

AND NET CASH PROVIDED BY OPERATING ACTIVITIES

(Unaudited)

 

 

 

Three Months
Ended March 31,

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2023

 

2023

 

2022

 

2023

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands of dollars)

Net cash provided by operating activities

 

$

144,860

 

 

$

98,543

 

 

$

120,857

 

 

$

243,403

 

 

$

225,667

 

Changes in operating assets and liabilities and other

 

 

(53,408

)

 

 

(23,279

)

 

 

(36,418

)

 

 

(76,687

)

 

 

(60,403

)

Net income

 

 

91,452

 

 

 

75,264

 

 

 

84,439

 

 

 

166,716

 

 

 

165,264

 

Add:

 

 

 

 

 

 

 

 

 

 

Depreciation, amortization and disposition of property, plant and equipment

 

 

27,003

 

 

 

27,095

 

 

 

31,469

 

 

 

54,098

 

 

 

65,722

 

Less:

 

 

 

 

 

 

 

 

 

 

Contribution to turnaround reserves

 

 

(7,306

)

 

 

(6,967

)

 

 

(7,284

)

 

 

(14,273

)

 

 

(14,488

)

Maintenance capital expenditures

 

 

(8,024

)

 

 

(6,521

)

 

 

(10,372

)

 

 

(14,545

)

 

 

(23,825

)

Distributable cash flow attributable to noncontrolling interest in OpCo

 

 

(85,574

)

 

 

(73,886

)

 

 

(78,668

)

 

 

(159,460

)

 

 

(153,798

)

MLP distributable cash flow

 

$

17,551

 

 

$

14,985

 

 

$

19,584

 

 

$

32,536

 

 

$

38,875

 

WESTLAKE CHEMICAL PARTNERS LP

 

RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH

PROVIDED BY OPERATING ACTIVITIES

(Unaudited)

 

 

 

Three Months
Ended March 31,

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2023

 

2023

 

2022

 

2023

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

(In thousands of dollars)

Net cash provided by operating activities

 

$

144,860

 

 

$

98,543

 

 

$

120,857

 

 

$

243,403

 

 

$

225,667

 

Changes in operating assets and liabilities and other

 

 

(53,408

)

 

 

(23,279

)

 

 

(36,418

)

 

 

(76,687

)

 

 

(60,403

)

Net income

 

 

91,452

 

 

 

75,264

 

 

 

84,439

 

 

 

166,716

 

 

 

165,264

 

Less:

 

 

 

 

 

 

 

 

 

 

Other income, net

 

 

820

 

 

 

1,061

 

 

 

90

 

 

 

1,881

 

 

 

65

 

Interest expense—Westlake

 

 

(7,315

)

 

 

(6,117

)

 

 

(2,859

)

 

 

(13,432

)

 

 

(5,058

)

Provision for income taxes

 

 

(212

)

 

 

(173

)

 

 

(175

)

 

 

(385

)

 

 

(338

)

Income from operations

 

 

98,159

 

 

 

80,493

 

 

 

87,383

 

 

 

178,652

 

 

 

170,595

 

Add:

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

26,636

 

 

 

27,040

 

 

 

31,009

 

 

 

53,676

 

 

 

62,291

 

Other income, net

 

 

820

 

 

 

1,061

 

 

 

90

 

 

 

1,881

 

 

 

65

 

EBITDA

 

$

125,615

 

 

$

108,594

 

 

$

118,482

 

 

$

234,209

 

 

$

232,951

 

 

Contact—(713) 585-2900

Investors—Steve Bender

Media—L. Benjamin Ederington

Source: Westlake Chemical Partners

WESTLAKE CHEMICAL PARTNERS LP

NYSE:WLKP

WLKP Rankings

WLKP Latest News

WLKP Stock Data

816.83M
19.25M
44.84%
33.76%
0.38%
Chemicals
Industrial Organic Chemicals
Link
United States of America
HOUSTON